000 | 01027 a2200265 4500 | ||
---|---|---|---|
005 | 20250517214646.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1434-9949 | ||
024 | 7 |
_a10.1007/s10067-018-4131-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDurez, Patrick | |
245 | 0 | 0 |
_aCorrection to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. _h[electronic resource] |
260 |
_bClinical rheumatology _c07 2018 |
||
300 |
_a2017-2018 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Published Erratum | ||
700 | 1 | _aPavelka, Karel | |
700 | 1 | _aLazaro, Maria Alicia | |
700 | 1 | _aGarcia-Kutzbach, Abraham | |
700 | 1 | _aMoots, Robert J | |
700 | 1 | _aAmital, Howard | |
700 | 1 | _aGovoni, Marinella | |
700 | 1 | _aVastesaeger, Nathan | |
773 | 0 |
_tClinical rheumatology _gvol. 37 _gno. 7 _gp. 2017-2018 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-018-4131-1 _zAvailable from publisher's website |
999 |
_c28382794 _d28382794 |